NCBI-Aggregator

  • Co-Design of a New Integrated Care Model With People Affected by Huntington's Disease: A Mixed Methods Study
    Health Expect. 2026 Feb;29(1):e70584. doi: 10.1111/hex.70584.ABSTRACTBACKGROUND: People living with neurological conditions have needs that require an integrated care approach. Existing models of integrated care have often emphasized system structures but neglected the micro-level interactions that matter most to people.OBJECTIVES: To develop a micro-level model for integrated care that represents the...Read more
    Source: NCBI Date: 2026-01-31 By Sandra Bartolomeu Pires
  • Executive Impairment in Huntington's Disease: Insights From a Systematic Review of the Literature
    Brain Behav. 2026 Feb;16(2):e71238. doi: 10.1002/brb3.71238.ABSTRACTPURPOSE: This systematic review examines executive dysfunction in Huntington's disease (HD), an inherited neurodegenerative disorder characterized by cognitive alterations that may emerge years before the onset of motor symptoms. The objective of this review is to provide an updated and comprehensive synthesis of executive function...Read more
    Source: NCBI Date: 2026-01-30 By Simone Migliore
  • Exploring huntington's disease from a neurodevelopmental perspective
    Int J Biol Sci. 2026 Jan 1;22(3):1233-1246. doi: 10.7150/ijbs.124552. eCollection 2026.ABSTRACTHuntington's disease (HD) is a rare, inherited neurodegenerative disorder caused by mutations in the huntingtin (HTT) gene. The classic concept is that HD is a degenerative disease that primarily affects the striatum, caused by a gain-of-function mutant mHTT that kills...Read more
    Source: NCBI Date: 2026-01-28 By Chunhui Huang
  • Non-Directiveness and Authenticity in the Predictive Genetic Clinic
    Sociol Health Illn. 2026 Feb;48(2):e70149. doi: 10.1111/1467-9566.70149.ABSTRACTThe predictive genetic clinic is a space where counsellors use non-directive counselling to facilitate asymptomatic patients at risk of carrying a dominantly inherited disease access a predictive genetic test. The social science literature has a history of examining practices within this clinic, but with...Read more
    Source: NCBI Date: 2026-01-28 By Shane Doheny
  • From Cancer to Neuroprotection: Pazopanib Modulates the RIPK1/RIPK3/MLKL and PGAM5/DRP1 Pathways in 3- Nitropropionic Acid-Induced Huntington's Disease
    Drug Dev Res. 2026 Apr;87(2):e70238. doi: 10.1002/ddr.70238.ABSTRACTHuntington's disease (HD) is a progressive neurodegenerative disorder with a poorly understood neurobiological basis. Among the various forms of programmed cell death implicated in neurodegeneration, necroptosis has recently garnered significant attention. Notably, dysregulated necroptosis provokes immune response that drives excessive pro-inflammatory cytokine production, promoting...Read more
    Source: NCBI Date: 2026-01-26 By Muhammad A Eltarzy
  • Decoding Non-Neuronal Mechanisms and Therapeutic Targets in Huntington's Disease Through Integrative Transcriptomics and Machine Learning
    J Mol Neurosci. 2026 Jan 19;76(1):11. doi: 10.1007/s12031-025-02463-z.ABSTRACTHuntington's disease (HD) is a rare, inherited neurodegenerative disorder caused by the expanded CAG repeats in the huntingtin gene. The HD domain still lacks detailed knowledge of validated drug targets, limiting the effectiveness of classical methods. To address this gap, we have applied...Read more
    Source: NCBI Date: 2026-01-18 By Himanshi Gupta
  • Astrocytic noncanonical WNT5B signaling modulates extracellular matrix remodeling and neuropathology in Huntington's disease
    Signal Transduct Target Ther. 2026 Jan 19;11(1):23. doi: 10.1038/s41392-025-02545-9.ABSTRACTHuntington's disease (HD) is a fatal neurodegenerative disorder characterized by a triad of behavioral symptoms: involuntary movement, emotional change, and cognitive dysfunction. Although alterations in WNT signaling have been reported in HD, its precise role in pathogenesis remains unclear. In this study,...Read more
    Source: NCBI Date: 2026-01-17 By Phuong Thi Thanh Nguyen
  • Discovery of disrupted sustained attention and altered functional connectivity in far-from-onset Huntington's disease gene-expanded young adults
    Alzheimers Dement. 2026 Jan;22(1):e70944. doi: 10.1002/alz.70944.ABSTRACTBACKGROUND: Cognitive impairments are a hallmark of Huntington's disease (HD).METHODS: Seventy-one participants (43 HD gene-expanded [HDGE], 28 healthy controls) from the HD-Young Adult Study at two timepoints ≈ 4.7 years apart, completed the Cambridge Neuropsychological Test Automated Battery Rapid Visual Information Processing task and underwent...Read more
    Source: NCBI Date: 2026-01-12 By Christelle Langley
  • Eye manifestations in Huntington's disease: an update on the potential of ocular biomarkers
    J Neurol. 2026 Jan 8;273(1):68. doi: 10.1007/s00415-025-13600-4.ABSTRACTHuntington's disease (HD) remains a devastating neurodegenerative disorder caused by CAG repeat expansion in the HTT gene. Biomarkers are urgently needed to facilitate more accurate evaluation of disease onset, progression, and response to interventions. Characteristic clinical features of the disease are secondary to neuronal...Read more
    Source: NCBI Date: 2026-01-07 By William A Woods
  • Programmed cell death pathways in huntington's disease: spotlight on ferroptosis and pyroptosis
    Neurol Sci. 2026 Jan 2;47(1):83. doi: 10.1007/s10072-025-08689-4.ABSTRACTHuntington's disease (HD) is characterized by dementia, delayed psychomotor processes, abnormal choreatic movements, and cognitive impairments. This condition is brought on by an increase in cytosine-adenine-guanine repeats in the huntingtin (Htt) gene on chromosome-4, which produces the Htt protein's poly-glutamine (poly-Q). Despite significant progress...Read more
    Source: NCBI Date: 2026-01-02 By Veerta Sharma
  • Huntington's disease presenting with schizophreniform psychosis and narcolepsy in the premotor phase
    Orv Hetil. 2025 Dec 28;166(52):2064-2072. doi: 10.1556/650.2025.33430. Print 2025 Dec 28.ABSTRACTThe authors report the case of a patient diagnosed and treated with schizophrenia for nearly 20 years. A rapid change in the neurological status of the patient necessitated a diagnostic revision. The patient's additional medical history included narcolepsy and psoriasis....Read more
    Source: NCBI Date: 2025-12-27 By Gyöngyi Szabó
  • Clinical Manifestations
    Alzheimers Dement. 2025 Dec;21 Suppl 3:e105286. doi: 10.1002/alz70857_105286.ABSTRACTBACKGROUND: Apathy and impulsivity co-occur in Huntington's disease (HD), but these debilitating behavioural syndromes are multidimensional constructs, raising the question of which specific dimensions drive this relationship, and the stability of the co-occurring dimensions across time.METHODS: People with HD and controls completed multidimensional...Read more
    Source: NCBI Date: 2025-12-25 By Lee-Anne Morris
  • Basic Science and Pathogenesis
    Alzheimers Dement. 2025 Dec;21 Suppl 1:e106520. doi: 10.1002/alz70855_106520.ABSTRACTBACKGROUND: Huntington's disease (HD) differs from Alzheimer's disease (AD) in its clinical presentation, particularly regarding vigilance, with notable motor, functional, and cognitive impairments that may be mirrored in resting-state electroencephalographic (rsEEG) rhythms.METHOD: To evaluate this hypothesis, clinical and rsEEG data were gathered from...Read more
    Source: NCBI Date: 2025-12-24 By Giuseppe Noce
  • Clinical Manifestations
    Alzheimers Dement. 2025 Dec;21 Suppl 3:e098429. doi: 10.1002/alz70857_098429.ABSTRACTBACKGROUND: Huntington's disease (HD) is marked by progressive cognitive decline, with early deficits often presenting long before motor symptoms. These changes are subtle yet profoundly impactful, underscoring the need for sensitive tools like the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L). The...Read more
    Source: NCBI Date: 2025-12-23 By Luis A Sierra
  • Neuronal mitochondrial disaggregase CLPB ameliorates Huntington's disease pathology in mice
    Theranostics. 2026 Jan 1;16(5):2388-2404. doi: 10.7150/thno.122651. eCollection 2026.ABSTRACTBackground: Huntington's disease (HD) is a devastating neurodegenerative disorder caused by CAG repeat expansion in the HTT gene, resulting in a polyglutamine-expanded huntingtin (HTT) protein that forms toxic aggregates. Although heat-shock proteins are known to facilitate the refolding or clearance of misfolded proteins,...Read more
    Source: NCBI Date: 2025-12-21 By Hyeonho Kim